Pacira BioSciences: Q3 Earnings Insights

Pacira BioSciences PCRX reported its Q3 earnings results on Thursday, November 3, 2022 at 08:00 AM.

Here's what investors need to know about the announcement.

Pacira BioSciences missed estimated earnings by 15.79%, reporting an EPS of $0.64 versus an estimate of $0.76.

Revenue was up $39.74 million from the same period last year.

Last quarter the company missed on EPS by $0.37 which was followed by a 0.54% drop in the share price the next day.

Here's a look at Pacira BioSciences's past performance:

Quarter	Q2 2022	Q1 2022	Q4 2021	Q3 2021
EPS Estimate	0.88	0.83	0.90	0.65
EPS Actual	0.51	0.64	0.97	0.72
Revenue Estimate	171.43M	159.49M	155.74M	130.38M
Revenue Actual	169.41M	157.99M	159.19M	127.72M

To track all earnings releases for Pacira BioSciences visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Earnings Calendar